Cargando…
Premotor biomarkers for Parkinson's disease - a promising direction of research
The second most serious neurodegenerative disease is Parkinson’s disease (PD). Over the past several decades, a strong body of evidence suggests that PD can begin years before the hallmark clinical motor symptoms appear. Biomarkers for PD are urgently needed to differentiate between neurodegenerativ...
Autores principales: | Haas, Brian R, Stewart, Tessandra H, Zhang, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514104/ https://www.ncbi.nlm.nih.gov/pubmed/23211054 http://dx.doi.org/10.1186/2047-9158-1-11 |
Ejemplares similares
-
Research on the Premotor Symptoms of Parkinson’s Disease: Clinical and Etiological Implications
por: Chen, Honglei, et al.
Publicado: (2013) -
Mesenchymal stromal cell biotherapy for Parkinson’s disease premotor symptoms
por: Sun, Jinmei, et al.
Publicado: (2023) -
Before the Tremor: Premotor Symptoms of Parkinson’s Disease
por: Konkel, Lindsey
Publicado: (2013) -
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
por: Tian, Chen, et al.
Publicado: (2019) -
Combining clinical and biofluid markers for early Parkinson's disease detection
por: Yu, Zhenwei, et al.
Publicado: (2017)